SCHEMBL4183254

SCHEMBL4183254

CCS(=O)(=O)c1ccc(-c2cnn(-c3cccc(Cl)c3)c(=O)c2C2CCCCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
TP53 P04637 3/20 0.41
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
ATM Q13315 1/20 0.40
PTGS2 P35354 2/20 0.39
CA4 P22748 3/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
SRC P12931 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4184739 0.90 PTGS2 (0.50) LMNATP53RAB9ANPC1ATM
SCHEMBL4180359 0.89 PTGS2 (0.51) RAB9ANPC1ATMPTGS2CA4
SCHEMBL27522824 0.83 RAB9A (0.42) LMNATP53RAB9ANPC1ATM
SCHEMBL27549348 0.82 RAB9A (0.42) LMNATP53RAB9ANPC1ATM
SCHEMBL5843303 0.79 SRC (0.40) LMNATP53RAB9ANPC1ATM
SCHEMBL4191613 0.79 PTGS2 (0.46) PTGS2PTGS1
SCHEMBL4186739 0.77 PTGS2 (0.47) PTGS2PTGS1
SCHEMBL4193605 0.77 PTGS2 (0.48) RAB9ANPC1ATMPTGS2CA4
SCHEMBL4189590 0.76 PTGS2 (0.48) RAB9ANPC1ATMPTGS2POLB
SCHEMBL8519579 0.75 PTGS2 (0.46) LMNATP53RAB9ANPC1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042888-A1 Prostaglandin endoperoxide H synthase biosynthesis inhibitors BLACK LAWRENCE A 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042888-A1 Prostaglandin endoperoxide H synthase biosynthesis inhibitors PTGIS, PTGS1, PTGS2 LMNA 3572/4885TP53 4800/4885RAB9A 4374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.